Dr. Eiswarya Chichili, MD

Dr. Chichili practices at St. Luke's Hospital - Warren Campus in Phillipsburg, New Jersey, part of St. Luke's University Health Network.

Dr. Chichili's NPI, 1376798074, was assigned on November 21, 2008. Dr. Chichili holds New Jersey license 25MA08509600.

Dr. Chichili's primary practice is St. Luke's Hospital - Warren Campus, at 185 Roseberry St, Phillipsburg, NJ 08865 in Warren County. The practice phone is (908) 847-6700.

Dr. Chichili's primary practice is St. Luke's Hospital - Warren Campus in Phillipsburg, New Jersey, part of St. Luke's University Health Network. Dr. Chichili is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's Warren Hills Family Practice. Dmand AI also links Dr. Chichili to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chichili practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chichili's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chichili is licensed in New Jersey.

CMS data shows 936 Medicare services from Dr. Chichili across 5 procedure codes in 2024, for 320 Medicare patients. Medicare paid $87,958 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 320 Medicare patients who saw Dr. Chichili in 2024. The largest group is 75 to 84, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chichili's median patient age at 77, with 50% women.

In 2024, Dr. Chichili wrote 207 Medicare Part D claims for 109 patients. 90% of them were for generic drugs. CMS names the drug for 53 of them, across 4 drugs with 11 or more claims each, at $374 in total drug cost. In 2023, CMS named 113 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Chichili for performance year 2024, reported through an alternative payment model (APM). Dr. Chichili accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 62 general payments to Dr. Chichili from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $456.